University of Minnesota 2015LS095 (MNCCTN006): Phase II Trial of Exemestane in Previously Treated Post-Menopausal Women With Advanced Non-Small Cell Lung Cancer

Objective

This is a phase II therapeutic study of adding exemestane therapy in post-menopausal women with advanced non-small cell lung cancer (NSCLC) who are progressing while on treatment with an immune checkpoint antibody (pembrolizumab, atezolizumab, or nivolumab).

https://clinicaltrials.gov/ct2/show/NCT02666105

Location: Essentia Health Cancer Centers

Research Study Categories

  • Adult Studies

Specialty

  • Lung Cancer
Contact
Cancer Clinical Trials at 218-786-3308
or cancertrials@essentiahelath.org

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn more.